GLUT1 mediates bronchial epithelial E-cadherin disruption in TDI-induced steroid-insensitive asthma

References

• Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, et al. Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes. Eur Respir J. 2021;59(1):2102730. doi:10.1183/13993003.02730-2021.
   PubMed Web of Science ®Google Scholar
• Wadhwa R, Dua K, Adcock IM, Horvat JC, Kim RY, Hansbro PM. Cellular mechanisms underlying steroid-resistant asthma. Eur Respir Rev. 2019;28(153):190096. doi:10.1183/16000617.0096-2019.
   PubMed Web of Science ®Google Scholar
• Inoue H, Akimoto K, Homma T, Tanaka A, Sagara H. Airway epithelial dysfunction in asthma: relevant to epidermal growth factor receptors and airway epithelial cells. J Clin Med. 2020;9(11):3698. doi:10.3390/jcm9113698.
   PubMed Web of Science ®Google Scholar
• Hellings PW, Steelant B. Epithelial barriers in allergy and asthma. J Allergy Clin Immunol. 2020;145(6):1499–1509. doi:10.1016/j.jaci.2020.04.0105.
   PubMed Web of Science ®Google Scholar
• Nawijn MC, Hackett TL, Postma DS, van Oosterhout AJ, Heijink IH. E-cadherin: gatekeeper of airway mucosa and allergic sensitization. Trends Immunol. 2011;32(6):248–255. doi:10.1016/j.it.2011.03.004.
   PubMed Web of Science ®Google Scholar
• Ghosh B, Loube J, Thapa S, Ryan H, Capodanno E, Chen D, Swaby C, Chen S, Mahmud S, Girgis M, et al. Loss of E-cadherin is causal to pathologic changes in chronic lung disease. Commun Biol. 2022;5(1):1149. doi:10.1038/s42003-022-04150-w.
   PubMed Web of Science ®Google Scholar
• Hu QP, Kuang JY, Yang QK, Bian XW, Yu S. Beyond a tumor suppressor: soluble E-cadherin promotes the progression of cancer. Int J Cancer. 2016;138(12):2804–2812. doi:10.1002/ijc.29982.
   PubMed Web of Science ®Google Scholar
• Heijink IH, Kies PM, Kauffman HF, Postma DS, van Oosterhout AJ, Vellenga E. Down-regulation of E-cadherin in human bronchial epithelial cells leads to epidermal growth factor receptor-dependent Th2 cell-promoting activity. J Immunol. 2007;178(12):7678–7685. doi:10.4049/jimmunol.178.12.7678.
   PubMed Web of Science ®Google Scholar
• Post S, Heijink IH, Hesse L, Koo HK, Shaheen F, Fouadi M, Kuchibhotla VNS, Lambrecht BN, Van Oosterhout AJM, Hackett TL, et al. Characterization of a lung epithelium specific E-cadherin knock-out model: implications for obstructive lung pathology. Sci Rep. 2018;8(1):13275. doi:10.1038/s41598-018-31500-8.
   PubMedGoogle Scholar
• Goto T, Ishizaka A, Katayama M, Kohno M, Tasaka S, Fujishima S, Kobayashi K, Nomori H. Involvement of E-cadherin cleavage in reperfusion injury. Eur J Cardiothorac Surg. 2010;37(2):426–431. doi:10.1016/j.ejcts.2009.06.041.
   PubMed Web of Science ®Google Scholar
• Evans SM, Blyth DI, Wong T, Sanjar S, West MR. Decreased distribution of lung epithelial junction proteins after intratracheal antigen or lipopolysaccharide challenge: correlation with neutrophil influx and levels of BALF sE-cadherin. Am J Respir Cell Mol Biol. 2002;27(4):446–454. doi:10.1165/rcmb.4776.
   PubMed Web of Science ®Google Scholar
• Masuyama K, Morishima Y, Ishii Y, Nomura A, Sakamoto T, Kimura T, Mochizuki M, Uchida Y, Sekizawa K. Sputum E-cadherin and asthma severity. J Allergy Clin Immunol. 2003;112(1):208–209. doi:10.1067/mai.2003.1526.
   PubMed Web of Science ®Google Scholar
• Melis L, Van Praet L, Pircher H, Venken K, Elewaut D. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-α production by interaction with its soluble E-cadherin ligand in chronically inflamed joints. Ann Rheum Dis. 2014;73(6):1223–1231. doi:10.1136/annrheumdis-2013-203881.
   PubMed Web of Science ®Google Scholar
• Tang MKS, Yue PYK, Ip PP, Huang RL, Lai HC, Cheung ANY, Tse KY, Ngan HYS, Wong AST. Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface. Nat Commun. 2018;9(1):2270. doi:10.1038/s41467-018-04695-7.
   PubMedGoogle Scholar
• Yao L, Chen S, Tang H, Huang P, Wei S, Liang Z, Chen X, Yang H, Tao A, Chen R, et al. Transient receptor potential ion channels mediate adherens junctions dysfunction in a toluene diisocyanate-induced murine asthma model. Toxicol Sci. 2019;168(1):160–170. doi:10.1093/toxsci/kfy285.
   PubMed Web of Science ®Google Scholar
• Thorens B, Mueckler M. Glucose transporters in the 21st century. Am J Physiol Endocrinol Metab. 2010;298(2):E141–5. doi:10.1152/ajpendo.00712.2009.
   PubMed Web of Science ®Google Scholar
• Hsueh YJ, Meir YJ, Lai JY, Huang CC, Lu TT, Ma DH, Cheng CM, Wu WC, Chen HC. Ascorbic acid ameliorates corneal endothelial dysfunction and enhances cell proliferation via the noncanonical GLUT1-ERK axis. Biomed Pharmacother. 2021;144:112306. doi:10.1016/j.biopha.2021.112306.
   PubMed Web of Science ®Google Scholar
• Beg M, Abdullah N, Thowfeik FS, Altorki NK, McGraw TE. Distinct Akt phosphorylation states are required for insulin regulated Glut4 and Glut1-mediated glucose uptake. Elife. 2017;6:e26896. doi:10.7554/eLife.26896.
   PubMed Web of Science ®Google Scholar
• Mo Y, Wang Y, Zhang S, Xiong F, Yan Q, Jiang X, Deng X, Wang Y, Fan C, Tang L, et al. Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2. Mol Cancer. 2021;20(1):112. doi:10.1186/s12943-021-01409-4.
   PubMed Web of Science ®Google Scholar
• Veys K, Fan Z, Ghobrial M, Bouché A, García-Caballero M, Vriens K, Conchinha NV, Seuwen A, Schlegel F, Gorski T, et al. Role of the GLUT1 glucose transporter in postnatal CNS angiogenesis and blood-brain barrier integrity. Circ Res. 2020;127(4):466–482. doi:10.1161/CIRCRESAHA.119.316463.
   PubMed Web of Science ®Google Scholar
• Renaudin F, Orliaguet L, Castelli F, Fenaille F, Prignon A, Alzaid F, Combes C, Delvaux A, Adimy Y, Cohen-Solal M, et al. Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages. Ann Rheum Dis. 2020;79(11):1506–1514. doi:10.1136/annrheumdis-2020-217342.
   PubMed Web of Science ®Google Scholar
• Tang H, Guo Y, Gan S, Chen Z, Dong M, Lin L, Chen H, Ji X, Xian M, Shi X, et al. GLUT1 mediates the release of HMGB1 from airway epithelial cells in mixed granulocytic asthma. Biochim Biophys Acta Mol Basis Dis. 2024;1870(3):167040. doi:10.1016/j.bbadis.2024.167040.
   PubMed Web of Science ®Google Scholar
• Zheng PP, Romme E, van der Spek PJ, Dirven CM, Willemsen R, Kros JM. Glut1/SLC2A1 is crucial for the development of the blood-brain barrier in vivo. Ann Neurol. 2010;68(6):835–844. doi:10.1002/ana.22318.
   PubMed Web of Science ®Google Scholar
• Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, Sengillo JD, Hillman S, Kong P, Nelson AR, et al. GLUT1 reductions exacerbate Alzheimer’s disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci. 2015;18(4):521–530. doi:10.1038/nn.3966.
   PubMed Web of Science ®Google Scholar
• Tang H, Chen Z, Gan S, Liang Y, Zhang H, Yang C, Lin L, Guo Y, Li S, Li J, et al. GLUT1 contributes to impaired epithelial tight junction in the late phase of acute lung injury. Eur J Pharmacol. 2023;961:176185. doi:10.1016/j.ejphar.2023.176185.
   PubMed Web of Science ®Google Scholar
• Chen R, Zhang Q, Chen S, Tang H, Huang P, Wei S, Liang Z, Chen X, Tao A, Yao L. IL-17F, rather than IL-17A, underlies airway inflammation in a steroid-insensitive toluene diisocyanate-induced asthma model. Eur Respir J. 2019;53(4):1801510. doi:10.1183/13993003.01510-2018.
   PubMed Web of Science ®Google Scholar
• Tarlo SM, Lemiere C. Occupational asthma. N Engl J Med. 2014;370(7):640–649. doi:10.1056/NEJMra1301758.
   PubMed Web of Science ®Google Scholar
• Johnson VJ, Yucesoy B, Luster MI. Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol. 2005;116(4):851–858. doi:10.1016/j.jaci.2005.07.008.
   PubMed Web of Science ®Google Scholar
• Devos FC, Pollaris L, Cremer J, Seys S, Hoshino T, Ceuppens J, Talavera K, Nemery B, Hoet PHM, Vanoirbeek JAJ. IL-13 is a central mediator of chemical-induced airway hyperreactivity in mice. PLoS One. 2017;12(7):e0180690. doi:10.1371/journal.pone.0180690.
   PubMed Web of Science ®Google Scholar
• De Vooght V, Vanoirbeek JA, Haenen S, Verbeken E, Nemery B, Hoet PH. Oropharyngeal aspiration: an alternative route for challenging in a mouse model of chemical-induced asthma. Toxicology. 2009;259(1-2):84–89. doi:10.1016/j.tox.2009.02.007.
   PubMed Web of Science ®Google Scholar
• Malo JL, Cartier A, Côté J, Milot J, Leblanc C, Paquette L, Ghezzo H, Boulet LP. Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: an 18-month double-blind crossover study. Am J Respir Crit Care Med. 1996;153(3):953–960. doi:10.1164/ajrccm.153.3.8630579.
   PubMed Web of Science ®Google Scholar
• Pelikan Z. Delayed asthmatic response: a new phenotype of bronchial response to allergen challenge and soluble adhesion molecules in the serum. Ann Allergy Asthma Immunol. 2011;106(2):119–130. doi:10.1016/j.anai.2010.11.002.
   PubMed Web of Science ®Google Scholar
• Zezina E, Sercan-Alp O, Herrmann M, Biesemann N. Glucose transporter 1 in rheumatoid arthritis and autoimmunity. Wiley Interdiscip Rev Syst Biol Med. 2020;12(4):e1483. doi:10.1002/wsbm.1483.
   PubMed Web of Science ®Google Scholar
• Deng D, Yan N. GLUT, SGLT, and SWEET: structural and mechanistic investigations of the glucose transporters. Protein Sci. 2016;25(3):546–558. doi:10.1002/pro.2858.
   PubMed Web of Science ®Google Scholar
• Molina SA, Moriarty HK, Infield DT, Imhoff BR, Vance RJ, Kim AH, Hansen JM, Hunt WR, Koval M, McCarty NA. Insulin signaling via the PI3-kinase/Akt pathway regulates airway glucose uptake and barrier function in a CFTR-dependent manner. Am J Physiol Lung Cell Mol Physiol. 2017;312(5):L688–L702. doi:10.1152/ajplung.00364.2016.
   PubMed Web of Science ®Google Scholar
• Liang Y, Zhang H, Li H, Wang X, Xie J, Li Y, Li J, Qian Y, Zhang H, Wang T, et al. GLUT1 regulates the release of VEGF-A in the alveolar epithelium of lipopolysaccharide-induced acute lung injury. Cell Biol Int. 2024;48(4):510–520. doi:10.1002/cbin.12127.
   PubMed Web of Science ®Google Scholar
• Ojelabi OA, Lloyd KP, Simon AH, De Zutter JK, Carruthers A. WZB117 (2-Fluoro-6-(m-hydroxybenzoyloxy) phenyl m-hydroxybenzoate) inhibits GLUT1-mediated sugar transport by binding reversibly at the exofacial sugar binding site. J Biol Chem. 2016; 291(52):26762–26772. doi:10.1074/jbc.M116.759175.
   PubMed Web of Science ®Google Scholar